Column Group LLC
CIK 1833486 · View on SEC EDGAR ↗
- Portfolio value
- $100.7M
- Positions
- 3
- As of
- March 31, 2026 Data as of Q1 2026
#7,768 of 8,643 by 13F value · top 89.9%
Portfolio value QoQ: +21.6% 13F does not disclose cash
- Top 10 holdings weight
- 100.00%
- Top 25 holdings weight
- 100.00%
- Positions above 1%
- 2
- Effective number of positions
- 2.0
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q2 2026: 0.0% Est. buys $0 · sells $0
Median holding: 7.0 quarters Tracked Q4 2024–Q2 2026 · 60.0% still held
- New positions
- 0
- Increased
- 0
- Decreased
- 0
- Closed
- 2
On this page
Sector breakdown
Healthcare
100.0%
Full portfolio 3 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| SRZN Surrozen, Inc. - Common Stock | $49,744,853 | 56.46% | 1,916,950 | $-6,095,901 | |||
| ORIC Oric Pharmaceuticals, Inc. - Common Stock | $38,346,615 | 43.53% | 3,540,777 | $-6,515,030 | |||
| RVMD Revolution Medicines, Inc. - Common Stock | $8,615 | 0.01% | 46 | $4,141 | |||
| No matches | |||||||
Top movers (QoQ)
Exited positions
Includes corporate events (mergers, delistings) — not all exits are sells
Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.
| Security | Quarter | Shares before | Value before | Price since exit |
|---|---|---|---|---|
| TNYA | March 31, 2026 | 9,400,290 | $6,693,006 | 4.0% |
| RAPT | March 31, 2026 | 156,270 | $5,292,878 | No longer tracked |